Prof. Marc AnsariChild and adolescent cancers require specific skills, in both the medical and care fields. A multidisciplinary approach is essential to provide the best treatment.
At the HUG, the Pediatric Hematology/Oncology Unit welcomes all children with cancer into a specifically designed facility and, as part of a program implemented with the Cancer Center, it provides the best expertise in the various medical specialties, at the hospital and within its network.
Consult the Pediatric Oncohematology Unit (FR) >>
This unit provides care for all types of cancer that can affect children, from the most common to the rarest: leukemia, lymphoma, brain tumors, sarcoma, etc.
Consult the types of cancer treated (FR) in the Pediatric Hematology/Oncology Unit
All the teams working within the Hematology/Oncology Unit and all the specialist physicians who make up the tumor board (weekly meetings) work together so that every child receives the best treatment and care. As a result, each child benefits from a personalized therapeutic strategy that is discussed by a group of physicians who are experts in the disease, working as a network to integrate all medical advances into the patient's care.
The Pediatric Hematology/Oncology Program ensures access to:
- specialist team meetings
- cutting-edge treatments
- innovative treatments in the context of clinical studies
In particular, therapeutic clinical trials have been implemented based on laboratory research performed. Within the Pediatric Hematology/Oncology Unit, scientific projects are being carried out in oncogenetics and pharmacogenetics to improve our understanding and treatment of cancer. Several foundations are financing these research projects: the Cansearch Foundation, the Dr. Henri Dubois-Ferrière Dinu Lipatti Foundation, the Geneva and Swiss League Against Cancer, the National Swiss Scientific Research Fund.
Find out more
Research in pediatric hematology/oncology (FR) >>